NI
Nozmul Islam Choudhury
About Nozmul Islam Choudhury
Data last updated:
Nozmul Islam Choudhury is a Director at Alstroemeria Healthcare Private Limited (since 2019) and Director at Danoma Pharmaceuticals Private Limited (since 2021). The companies operate in Business Services and Chemicals. The largest current company by reported revenue is Alstroemeria Healthcare Private Limited at ₹3.5 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jan 2019 | 2019 | ₹3.5 Lakh (FY 2020) | Active | |
| Director | 28 Jul 2021 | 2021 | Active |
Board colleagues of Nozmul Islam Choudhury
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abu Bakkar Laskar | 08333727 | Alstroemeria Healthcare Private Limited | Director |
| Sameer Ranjan Jha | 08333728 | Alstroemeria Healthcare Private Limited | Director |
| Prabir Borah | 09258155 | Danoma Pharmaceuticals Private Limited | Director |
| Shamme Akhter | 08489887 | Danoma Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nozmul Islam Choudhury
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nozmul Islam Choudhury
Nozmul Islam Choudhury currently holds 2 directorships: Alstroemeria Healthcare Private Limited (Director, since 16 Jan 2019, revenue ₹3.5 Lakh (FY 2020)); Danoma Pharmaceuticals Private Limited (Director, since 28 Jul 2021).
Nozmul Islam Choudhury was first appointed on 16 Jan 2019 as Director at Alstroemeria Healthcare Private Limited. The most recent appointment on record is 28 Jul 2021 at Danoma Pharmaceuticals Private Limited.
The current boards of Nozmul Islam Choudhury's companies include Abu Bakkar Laskar (Alstroemeria Healthcare Private Limited), Sameer Ranjan Jha (Alstroemeria Healthcare Private Limited), Prabir Borah (Danoma Pharmaceuticals Private Limited), Shamme Akhter (Danoma Pharmaceuticals Private Limited).